πŸ‡ΊπŸ‡Έ FDA
Patent

US 7737151

Pyrazine kinase inhibitors

granted A61PA61P11/06A61P25/00

Quick answer

US patent 7737151 (Pyrazine kinase inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon Jun 10 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Jun 15 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 10 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61P, A61P11/06, A61P25/00, A61P29/00, A61P35/00